Rubicon Research IPO: Price, Dates, Lot Size, Employee Discount | BSE NSE | Forgeup
Incorporated in 1999, Rubicon Research Limited develops, manufactures, and commercializes differentiated formulations across regulated markets. As of June 30, 2025, the portfolio includes 72 active ANDA/NDA approvals in the US with 66 commercialized products, alongside 17 pending ANDAs and 63 pipeline products under development. Rubicon Research IPO Mainboard book‑built issue (Fresh + Offer for Sale […]












